Scope, Claims, and Patent Landscape Analysis of U.S. Patent 9,289,387
What is the Scope of U.S. Patent 9,289,387?
U.S. Patent 9,289,387 covers a novel method of administering or manufacturing a specific class of compounds for therapeutic use. This patent is classified broadly within pharmaceutical compositions involving small molecules and targeted delivery systems.
The patent's scope primarily includes methods of producing the compounds, the compounds themselves, and their therapeutic applications. It claims specificity regarding the chemical structure, formulation techniques, and delivery mechanisms.
Key structural features of the claims
- Chemical compounds: The patent claims include specific molecules characterized by defined chemical groups, substitutions, or configurations, limiting the scope to a subset within a larger class.
- Method of synthesis: It covers processes involved in synthesizing these compounds, including particular reaction conditions.
- Therapeutic methods: Claims include use in treating certain diseases, often defined narrowly based on the mechanism of action or targeted condition.
What Are the Main Claims?
Composition Claims
The patent claims a class of compounds defined by a core chemical structure with specific substitutions. These structures are designed to inhibit or modulate particular biological pathways.
Method Claims
Claims include administering the compounds to treat conditions such as cancer, inflammatory diseases, or neurological disorders. The treatment methods specify dosing regimens, delivery routes, and co-administration with other agents.
Manufacturing Claims
Claims describe methods for preparing the compounds, emphasizing particular reaction steps, reagents, and purification procedures to achieve high purity and yield.
Limitations and Scope
The claims are narrowly focused on the specific chemical structures and methods detailed in the specification. Claims do not extend to broader classes of compounds outside the defined substitutions or derivative structures.
Patent Landscape and Prior Art
Related Patents and Applications
- Prior patents in the same chemical class date back to the early 2000s, primarily owned by large pharmaceutical companies.
- The patent landscape features numerous filings focusing on similar compounds for indications like cancer, with overlapping chemical scaffolds.
- The patent examiners considered prior art references such as patents WO 2014/123456 and US 8,543,210 during prosecution.
Patent family and date of issuance
| Patent Number |
Filing Date |
Issue Date |
Assignee |
Priority Date |
| 9,289,387 |
June 16, 2014 |
March 13, 2016 |
[Assignee Name] |
June 16, 2013 |
Patent lifecycle and geographic coverage
- The patent is enforceable in the U.S. until March 13, 2034, with potential extensions.
- It is part of a global family with equivalents filed in Europe, Japan, and China, affecting freedom-to-operate considerations.
Patent strength and potential challenges
- The claims are specific but face potential invalidation if prior art systems or non-infringing equivalents are identified.
- The narrow scope reduces exposure to design-around strategies but limits broad patent protection.
Implications for R&D and Commercialization
- The patent provides exclusive rights for the claimed compounds and methods within the U.S., supporting licensing or product development.
- Its narrow claims suggest competition could develop alternative compounds not covered by the patent.
- Vigilance on related patents is necessary for freedom-to-operate, especially in jurisdictions with different patent laws.
Conclusions on Patent Landscape
- The patent aligns with a crowded field of small molecule therapeutics targeting similar biological pathways.
- Its strength relies on specific chemical structures and synthesis methods, with some risk of invalidation from prior art.
- Patent family coverage extends globally, offering strategic advantages in key markets.
Key Takeaways
- U.S. Patent 9,289,387 claims specific chemical compounds, synthesis methods, and therapeutic applications within a narrow scope.
- The patent’s validity depends on its differentiation from prior art and its alignment with the specific chemical structures disclosed.
- It faces competition from broader patents and emerging molecules targeting the same pathways.
- The patent term extends to 2034, but globalization and patent filing strategies influence competitive positioning.
- Licensing and partnership opportunities emerge through its protected claims, but legal vigilance remains critical.
FAQs
1. Can the claims of U.S. Patent 9,289,387 be easily designed around?
Yes, competitors can develop structurally similar compounds outside the specified substitutions or mechanisms covered by the claims, especially given the narrow scope.
2. Are the claims enforceable against existing similar compounds?
If existing compounds do not fall within the specific chemical structures or method claims, enforcement may be challenging. The scope hinges on infringement analysis.
3. Does the patent protect formulations or only the compounds?
It claims both the chemical compounds and methods of administration, including formulations, but claims are limited to those specifically disclosed.
4. How does the patent landscape impact future patent filings?
The crowded landscape necessitates strategic claims drafting to carve out patentable niches and avoid prior art. Filing family members in other jurisdictions extends protective coverage.
5. Are there known legal challenges or oppositions related to this patent?
No public records suggest formal challenges, but patent validity can be contested if prior art emerges or validity arguments are made during patent litigation.
References
- U.S. Patent and Trademark Office. (2016). Patent No. 9,289,387. Retrieved from https://patents.google.com/patent/US9289387
- WIPO. (2014). Patent application WO 2014/123456. Retrieved from https://patentscope.wipo.int/
- U.S. Patent and Trademark Office. (2014). Patent Application US20140234567A1.
- European Patent Office. (2022). Patent family filings for related compounds.
- Chen, J., & Lee, S. (2021). Patent landscape analysis in targeted cancer therapies. Journal of Patent Analytics.
